Cargando…

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources

PURPOSE: High-dose chemotherapy with autologous stem-cell rescue (SCR) is a key component of high-risk neuroblastoma (HRNB) therapy. Carboplatin, etoposide, and melphalan (CEM) or busulfan and melphalan (Bu/Mel) are the most evaluated, effective high-dose chemotherapy for HRNB on the basis of result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elzembely, Mahmoud M., Park, Julie R., Riad, Khaled F., Sayed, Heba A., Pinto, Navin, Carpenter, Paul A., Baker, K. Scott, El-Haddad, Alaa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223425/ https://www.ncbi.nlm.nih.gov/pubmed/30241255 http://dx.doi.org/10.1200/JGO.17.00118

Ejemplares similares

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
por: Suwannaying, Kunanya, et al.
Publicado: (2022)

Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
por: Utriainen, Pauliina, et al.
Publicado: (2019)

A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group study ANBL00P1
por: Seif, Alix E., et al.
Publicado: (2013)

High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
por: Suh, Jung Min, et al.
Publicado: (2009)

Effective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked to Hematopoietic Stem Cell Transplantation in a Resource Limited Setting
por: Khaled, Safaa A. A., et al.
Publicado: (2023)

Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma
por: Tanos, Rachel, et al.
Publicado: (2016)

Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
por: Avitabile, Marianna, et al.
Publicado: (2020)

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction
por: Cupit-Link, Margaret, et al.
Publicado: (2023)

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
por: Herd, Fiona, et al.
Publicado: (2019)

Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients
por: Voglino, Valerio, et al.
Publicado: (2021)

High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy
por: El Kebbi, Ola, et al.
Publicado: (2023)

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.
por: Pinkerton, C. R., et al.
Publicado: (1990)

Treatment results and prognostic factors of pediatric neuroblastoma: a retrospective study
por: El-Sayed, Mohamed I, et al.
Publicado: (2010)

Management of neuroblastoma in limited-resource settings
por: van Heerden, Jaques, et al.
Publicado: (2020)

Immunotherapy for High-Risk Neuroblastoma: Management of Side Effects and Complications
por: Armideo, Erin, et al.
Publicado: (2017)

Treatment of high-risk neuroblastoma
por: Sung, Ki Woong
Publicado: (2012)

Treatment of High-Risk Neuroblastoma
por: Krystal, Julie, et al.
Publicado: (2023)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
por: Chen, Tingting, et al.
Publicado: (2022)

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
por: Makvandi, Mehran, et al.
Publicado: (2022)

Reporting Incidences of Neuroblastoma in Various Resource Settings
por: van Heerden, Jaques, et al.
Publicado: (2021)

MBCL-32. HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOR RECURRENT PREVIOUSLY IRRADIATED MEDULLOBLASTOMA
por: Salnikova, Ekaterina, et al.
Publicado: (2020)

The genetic landscape of high-risk neuroblastoma
por: Pugh, Trevor J., et al.
Publicado: (2013)

High-Risk Neuroblastoma Treatment Review
por: Smith, Valeria, et al.
Publicado: (2018)

Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapy
por: Zhang, Mengting, et al.
Publicado: (2022)

Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2018)

Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol
por: Zhang, Dongdong, et al.
Publicado: (2021)

Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy
por: Lu, Xian-Ying, et al.
Publicado: (2022)

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
por: Olgun, Nur, et al.
Publicado: (2022)

Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue
por: Buchbinder, David, et al.
Publicado: (2009)

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
por: Bae, Soo Jin, et al.
Publicado: (2012)

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
por: Sung, Ki Woong, et al.
Publicado: (2002)

Integrative discovery of treatments for high-risk neuroblastoma
por: Almstedt, Elin, et al.
Publicado: (2020)

Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman, Wayne L
Publicado: (2021)

High-Risk Neuroblastoma: A Surgical Perspective
por: Jacobson, Jillian C., et al.
Publicado: (2023)

Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2019)

Efficacy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Rescue in Patients Over 1 Year of Age with Stage 4 Neuroblastoma: The Korean Society of Pediatric Hematology-Oncology Experience Over 6 Years (2000-2005)
por: Sung, Ki Woong, et al.
Publicado: (2010)

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
por: Pession, A., et al.
Publicado: (1998)

Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models
por: Fischer-Mertens, Janina, et al.
Publicado: (2022)

Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma
por: Florea, Ana-Maria, et al.
Publicado: (2017)

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
por: Nicolaides, Theodore, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sg6m7miloum1h2dr8l51fhl0m4